A visionary biotech innovator, Ricky Chiu invented a proprietary, easy-to-use sample preparation technology that not only makes many diagnostic tools faster and easier to use, but also more accurate and affordable. He has successfully applied this novel technology in early cancer diagnostics and rapid point-of-care testing for infectious diseases. Using this core technology during the pandemic, he was able to quickly develop a series of COVID-19 diagnostic products, including the INDICAID® COVID-19 Rapid Antigen Test. Authorized by the US FDA and various health departments around the world, this test has helped prevent and control the spread of the COVID-19 virus here and overseas.
“The best way to predict the future is to create it!”